Table 1.
Question* | Strongly disagree | Disagree | Neither agree nor disagree | Agree | Strongly agree |
---|---|---|---|---|---|
The prevalence of FeLV in my practice area is too low | 3 (2.8) |
4 (3.8) |
14 (13.2) |
34 (32.1) | 51 (48.1) |
The cost of vaccination is prohibitive to my clients | 10 (9.4) |
29 (27.4) |
50 (47.2) |
13 (12.3) |
4 (3.8) |
The risks of adverse effects from the vaccine are not outweighed by the benefits | 5 (4.7) |
22 (20.8) |
38 (35.8) |
27 (25.5) |
14 (13.2) |
The vaccine does not provide adequate protection against FeLV | 5 (4.7) |
24 (22.6) |
67 (63.2) |
7 (6.6) |
2 (1.9) |
Data are n (%)
Six survey respondents did not provide answers to these questions